Skip to Main Content

Paper Details

Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups.
Leukemia
127
2018
CNAs, PRDM1 gene, genomic lesions, multiple myeloma, myeloma, patients, tumor
Author NameAffiliation
Giulia BianconUniversity of Milan
Laura MudieWellcome Trust Sanger Institute
Sarah O'MearaWellcome Trust Sanger Institute
Keiran RaineWellcome Trust Sanger Institute
Jon TeagueWellcome Trust Sanger Institute
Adam ButlerWellcome Trust Sanger Institute
Moritz GerstungEuropean Bioinformatics Institute
Kenneth C AndersonHarvard Medical School, LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Dana-Farber Cancer Institute
Kenneth C AndersonHarvard Medical School, LeBow Institute for Myeloma Therapeutics and Jerome Lipper Center for Multiple Myeloma Research, Dana-Farber Cancer Institute
Peter J CampbellWellcome Trust Sanger Institute
  • 1 - 10

Datasets

Release 1.2